Medical Imaging and Interventional Radiology: Current Updates and Clinical Challenges

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".

Deadline for manuscript submissions: 31 August 2024 | Viewed by 607

Special Issue Editors


E-Mail
Guest Editor
Department of Radiology, The University of Medicine and Pharmacy “Carol Davila”, 050474 Bucharest, Romania
Interests: abdominal medical imaging; abdominal interventional radiology; computed tomography; magnetic resonance; diagnostic imaging; ultrasound imaging; hepatocellular carcinoma; liver transplant

E-Mail Website
Guest Editor
Department of Radiology and Medical Imaging, Fundeni Clinical Institute, 022328 Bucharest, Romania
Interests: radiology; medical imaging; interventional radiology

Special Issue Information

Dear Colleagues,

Interventional radiology (IR), which emerged as a specialty in which imaging guidance is used as a tool for both diagnosis and therapy, is inherently case-specific.

This Special Issue aims to scrutinize the transformative impact of IR across various medical domains, assessing its integration in patient management, diagnostic processes, and therapeutic interventions. It will underscore recent advancements, novel innovations, and pivotal clinical research within this rapidly evolving field, focusing on outcomes, safety profiles, and efficacy measures.

This Special Issue will also provide insights into the future directions of image-guided minimally invasive procedures by highlighting new developments, obstacles, and prospects for improvement. Under the combined experience and input of distinguished scholars and professionals, this Special Issue hopes to be a useful tool that promotes discussion, information sharing, and developments in contemporary medicine.

Dr. Mugur Cristian Grasu
Prof. Dr. Ioana Gabriela Lupescu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • interventional radiology
  • diagnostic imaging
  • computed tomography
  • diagnostic radiology
  • magnetic resonance
  • ultrasound imaging

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 2121 KiB  
Article
Short- and Long-Term Outcomes after Radiofrequency Ablation of Osteoid Osteomas
by Thomas J. Vogl, Michael Bialek, Katrin Eichler, Renate Hammerstingl, John Bielfeldt, Stephan Zangos, Jan-Erik Scholtz and Hamzah Adwan
J. Pers. Med. 2024, 14(4), 401; https://doi.org/10.3390/jpm14040401 - 10 Apr 2024
Viewed by 474
Abstract
The aim of this study was to evaluate treatment of osteoid osteomas using bipolar radiofrequency ablation (RFA) and patients’ quality of life before and after therapy. We retrospectively evaluated patients who underwent bipolar RFA of osteoid osteomas between 2001 and 2016. We assessed [...] Read more.
The aim of this study was to evaluate treatment of osteoid osteomas using bipolar radiofrequency ablation (RFA) and patients’ quality of life before and after therapy. We retrospectively evaluated patients who underwent bipolar RFA of osteoid osteomas between 2001 and 2016. We assessed patients’ symptoms before and after treatment (four weeks after treatment and long-term) using a questionnaire including severity and quality of pain on a 10-point scale (1 = no pain, 10 = severe pain), motion restrictions, pain-related sleep disorders, and necessary pain medication. In addition, we evaluated technical success, complications, hospitalization length, and patients’ satisfaction with treatment. This study included 62 patients (43 [69.4%] males, 26.2 ± 13.2 years). Average nidus size was 5.7 ± 2.6 mm. The rate of technical success was 100%. All RFAs were performed without any complications. One patient showed a recurrence, resulting in a recurrence rate of 1.6%, which was successfully treated by another session of RFA. Average hospitalization length was 1.5 ± 0.5 days. A total of 36 patients (58.1%) participated in the questionnaire, reporting an average pain severity of 8.2 ± 1.6 before RFA compared to 3.4 ± 3.0 four weeks after and an average of 2.1 ± 2.3, 6.6 years after therapy, (both p < 0.001). After therapy, 31 (86.1%) patients had no pain. The majority of patients (n = 34, 94.4%) had reduced or absent motion restriction after therapy (p < 0.001). Patient satisfaction rate was 91.7%. In conclusion, bipolar RFA is a safe and effective treatment modality for osteoid osteomas and improves quality of life by reducing pain severity and motion restrictions. Full article
Show Figures

Figure 1

Back to TopTop